Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Jun 2022 | Jun 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 343.29M | 270.28M | 233.29M | 221.34M | 245.25M |
Gross Profit | 187.61M | 131.46M | -64.36M | 21.23M | -21.56M |
EBITDA | 51.35M | -12.34M | -210.74M | -1.55B | -535.28M |
Net Income | 1.59M | -69.33M | -265.33M | -1.72B | -693.63M |
Balance Sheet | |||||
Total Assets | 852.67M | 838.67M | 926.32M | 1.08B | 2.60B |
Cash, Cash Equivalents and Short-Term Investments | 138.47M | 117.47M | 300.84M | 439.14M | 425.21M |
Total Debt | 104.58M | 104.79M | 227.52M | 269.49M | 399.55M |
Total Liabilities | 244.07M | 236.80M | 409.19M | 422.00M | 567.03M |
Stockholders Equity | 567.17M | 559.77M | 486.08M | 661.84M | 2.04B |
Cash Flow | |||||
Free Cash Flow | -2.85M | -85.46M | -127.95M | -142.48M | -263.66M |
Operating Cash Flow | 16.00M | -68.51M | -115.82M | -110.27M | -210.58M |
Investing Cash Flow | -14.33M | -5.49M | -27.29M | -36.17M | -26.91M |
Financing Cash Flow | -116.00K | -47.92M | -56.48M | 147.78M | 521.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
51 Neutral | $368.41M | 112.35 | 3.05% | ― | 26.98% | ― | |
46 Neutral | C$201.68M | -3.23 | -23.14% | 1.87% | 20.75% | -0.36% | |
― | $230.50M | ― | -122.10% | ― | ― | ― | |
― | $203.35M | 22.50 | 4.76% | ― | ― | ― | |
― | $276.92M | ― | -17.34% | ― | ― | ― | |
62 Neutral | C$196.10M | ― | -38.89% | ― | -6.80% | 11.94% | |
― | $166.91M | ― | -554.70% | ― | ― | ― |
Aurora Cannabis announced it will host a conference call on August 6, 2025, to discuss its financial results for the first quarter of 2026. The call will be led by CEO Miguel Martin and CFO Simona King, and it aims to provide insights into the company’s financial performance and strategic direction. This announcement is significant as it reflects Aurora’s ongoing commitment to transparency and engagement with investors, potentially impacting its market positioning and stakeholder relations.
The most recent analyst rating on (TSE:ACB) stock is a Hold with a C$8.50 price target. To see the full list of analyst forecasts on Aurora Cannabis stock, see the TSE:ACB Stock Forecast page.
Aurora Cannabis Inc. has achieved its first-ever EU-GMP certification for its dedicated distribution centre in Brampton, Ontario, enhancing its international export capabilities. This certification, which aligns with European Union standards, allows Aurora to optimize its global supply chain and ensure consistent access to high-quality medical cannabis for patients worldwide, reinforcing its position as a leading exporter in the industry.
The most recent analyst rating on (TSE:ACB) stock is a Hold with a C$8.50 price target. To see the full list of analyst forecasts on Aurora Cannabis stock, see the TSE:ACB Stock Forecast page.
Aurora Cannabis Inc. has announced the availability of its management information circular for the upcoming annual general and special meeting of shareholders. The meeting, scheduled for August 8, 2025, will be held virtually, allowing shareholders worldwide to participate. Aurora’s board recommends voting in favor of all director nominees and meeting resolutions, emphasizing the importance of shareholder participation. This announcement underscores Aurora’s commitment to transparent governance and active shareholder engagement, potentially impacting its industry positioning and stakeholder relations.
The most recent analyst rating on (TSE:ACB) stock is a Hold with a C$8.50 price target. To see the full list of analyst forecasts on Aurora Cannabis stock, see the TSE:ACB Stock Forecast page.
Aurora Cannabis announced it will host a conference call on June 18, 2025, to discuss its fourth quarter and fiscal year 2025 financial results. This announcement highlights the company’s commitment to transparency and engagement with investors, which could impact its market positioning and stakeholder relations positively.
The most recent analyst rating on (TSE:ACB) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on Aurora Cannabis stock, see the TSE:ACB Stock Forecast page.